miR‐21 has been shown to drive chemoresistance by targeting PDCD4, PTEN or other genes in several solid tumours, such as renal carcinoma, hepatocellular carcinoma, colon carcinoma and gastric cancer cells.25, 26, 27. Here, PDCD4 is linked to hepatocellular carcinoma.